Testing effectiveness (Phase 2)Ended earlyNCT04042623What this trial is testingStudy of Safety and Efficacy of AVB-S6-500 in Patients With IgA NephropathyWho this might be right forIgA Nephropathy Aravive, Inc. 1
Large-scale testing (Phase 3)Looking for participantsNCT07390123What this trial is testingPhase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgANWho this might be right forIgA Nephropathy (IgAN) Haisco Pharmaceutical Group Co., Ltd. 370
Not applicableNot Yet RecruitingNCT07481084What this trial is testingIgA Nephropathy Insights From Treatment Experience Among Patients Receiving Iptacopan and/or Atrasentan Using Primary Data CollectionWho this might be right forIgA Nephropathy Novartis Pharmaceuticals 80
Testing effectiveness (Phase 2)Looking for participantsNCT04183101What this trial is testingEvaluation of a Renin Inhibitor, Aliskiren, Compared to Enalapril, in C3 GlomerulopathyWho this might be right forC3 GlomerulopathyMembranoproliferative GlomerulonephritisComplement Abnormality+2 more Region Skane 30
Large-scale testing (Phase 3)Active Not RecruitingNCT03747159What this trial is testingSynergetic B-cell Immunomodulation in SLE - 2nd Study.Who this might be right forLupus Erythematosus, Systemic Leiden University Medical Center 70
Not applicableNot Yet RecruitingNCT06610422What this trial is testingAssociation Between Neuropathy and Some Autoantibodies in Systemic Lupus Erythematosus (SLE) PatientsWho this might be right forLupus Nephritis Assiut University 159
Not applicableStudy completedNCT02527902What this trial is testingAutonomic Nervous System (ANS) and Renal Function in Immunoglobin A (IgA) NephropathyWho this might be right forIGA Glomerulonephritis Centre Hospitalier Universitaire de Saint Etienne 12
Large-scale testing (Phase 3)Active Not RecruitingNCT04557462What this trial is testingA Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA NephropathyWho this might be right forPrimary IgA Nephropathy Novartis Pharmaceuticals 448
Post-approval studies (Phase 4)Ended earlyNCT02226341What this trial is testingACTHar in the Treatment of Lupus NephritisWho this might be right forLupus Nephritis Columbia University 8
Not applicableStudy completedNCT05195086What this trial is testingA Pharmacoeconomic Study Comparing the Use of Mycophenolate Mofetil or Cyclophosphamide as Induction Therapy in Lupus Nephritis Patients in EgyptWho this might be right forLupus Nephritis Nada Magdy Mansour 122
Large-scale testing (Phase 3)Ended earlyNCT01765842What this trial is testingComparison of the Efficacy of Two Rituximab Treatment Regimens in Patients With Lupus NephropathyWho this might be right forLupus Nephritis Fundación Pública Andaluza Progreso y Salud 9
Testing effectiveness (Phase 2)Ended earlyNCT05162066What this trial is testingStudy to Evaluate the Safety, Tolerability of BCX9930 in Participants With Either Complement 3 Glomerulopathy (C3G), Immunoglobulin A Nephropathy (IgAN), or Primary Membranous Nephropathy (PMN)Who this might be right forComplement 3 GlomerulopathyImmunoglobulin A NephropathyMembranous Nephropathy BioCryst Pharmaceuticals 2
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06687174What this trial is testingStudy to Evaluate the Efficacy and Safety of MY008211A in Subjects with Primary Immunoglobulin a Nephropathy (IgAN)Who this might be right forIgA Nephropathy (IgAN) Wuhan Createrna Science and Technology Co., Ltd 72
Testing effectiveness (Phase 2)Looking for participantsNCT06947460What this trial is testingCD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAHWho this might be right forRefractory Lupus NephritisSystemic SclerosisPrimary Sjogren's Syndrome Combined With Pulmonary Hypertension+1 more Beijing GoBroad Hospital 45
Not applicableUnknownNCT03184103What this trial is testingAcute Post Streptococcal GlomerulonephritisWho this might be right forPSGN - Post-Streptococcal Glomerulonephritis Assiut University 50
Testing effectiveness (Phase 2)Study completedNCT06717815What this trial is testingPhase IIa Study for IPG11406 in Patients With Lupus NephritisWho this might be right forLupus Nephritis Nanjing Immunophage Biotech Co., Ltd 24
Post-approval studies (Phase 4)UnknownNCT05933213What this trial is testingComparing Mescaline Sodium Enteric-coated Tablets vs Morte-mescaline in the Treatment of Adult Lupus NephritisWho this might be right forLupus Nephritis Xiangya Hospital of Central South University 205
Large-scale testing (Phase 3)Study completedNCT02256150What this trial is testingEvaluate the Efficacy and Safety of Mizoribine in the Treatment of Lupus NephritisWho this might be right forLupus Nephritis Asahi Kasei Therapeutics Corporation 250
Not applicableLooking for participantsNCT07074951What this trial is testingTonsillectomy and Immunosuppression in Caucasian Patients With High-risk IgA-nephropathyWho this might be right forPrimary IgA-nephropathyHigh-riskCaucasians St. Petersburg State Pavlov Medical University 240
Large-scale testing (Phase 3)Ended earlyNCT00626197What this trial is testingEvaluate Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus (BELONG)Who this might be right forLupus NephritisSystemic Lupus Erythematosus Genentech, Inc. 381